Tarsus Pharmaceuticals, Inc. TARS Change in Prepaids
Change in Prepaids at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s change in prepaids.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s change in prepaids?
- Tarsus Pharmaceuticals, Inc. (TARS) reported change in prepaids of $13.24M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s change in prepaids changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s change in prepaids increased by 251.8% year-over-year, from -$8.73M to $13.24M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s change in prepaids?
- Over 3 years (2022 to 2025), Tarsus Pharmaceuticals, Inc.'s change in prepaids has grown at a 33.5% compound annual growth rate (CAGR), from $721K to -$1.72M.
- What does change in prepaids mean?
- This measures the net change in payments made in advance for goods or services that will be consumed in future periods. An increase indicates cash outflows for future benefits, while a decrease represents the consumption of previously paid assets. It serves as a key indicator of working capital efficiency and near-term cash management.